Literature DB >> 16876365

Dural tail sign in spinal meningiomas.

Ibrahim A Alorainy1.   

Abstract

OBJECTIVE: To study the association between the "dural tail sign" and spinal meningiomas on MR imaging.
METHODS: Retrospective review of MR examinations of all pathologically proven spinal meningiomas from 1998 to 2005 was performed. Lesions were evaluated for size, signal intensity, enhancement pattern, and presence or absence of dural tail. The dural tail length and direction in reference to the meningioma were also evaluated.
RESULTS: Seven spinal meningiomas were identified in seven patients. One lesion was purely extradural, while the remaining were intradural extramedullary. Dural tail was present in four cases (57%) and its length ranged between 5 and 21 mm. The tail was seen cranial and caudal to the meningioma in three cases and only cranially in one. Coronal images were available in three cases and in two of these; the dural tail was clearly depicted.
CONCLUSIONS: "Dural tail sign" is as common in spinal meningiomas as in cranial meningiomas.

Entities:  

Mesh:

Year:  2006        PMID: 16876365     DOI: 10.1016/j.ejrad.2006.06.012

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  3 in total

1.  Differentiation between intraspinal schwannoma and meningioma by MR characteristics and clinic features.

Authors:  Xiaodong Zhai; Ming Zhou; Hongwei Chen; Qunfeng Tang; Zhimin Cui; Yong Yao; Qihua Yin
Journal:  Radiol Med       Date:  2019-01-25       Impact factor: 3.469

2.  Radiological findings of spinal schwannomas and meningiomas: focus on discrimination of two disease entities.

Authors:  Wei Chiang Liu; Gun Choi; Sang-Ho Lee; Heon Han; Ji Yeon Lee; Yong Hwan Jeon; Hyeon Seon Park; Ji Young Park; Sung Suk Paeng
Journal:  Eur Radiol       Date:  2009-06-06       Impact factor: 5.315

3.  Clinical features and prognostic factors in spinal meningioma surgery from a multicenter study.

Authors:  Kazuyoshi Kobayashi; Kei Ando; Tomohiro Matsumoto; Koji Sato; Fumihiko Kato; Tokumi Kanemura; Hisatake Yoshihara; Yoshihito Sakai; Atsuhiko Hirasawa; Hiroaki Nakashima; Shiro Imagama
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.